2022 Ljubljana, Slovenia

I-15 Alan Faraj
Model-informed dose selection in phase-3 trials for prophylactic treatment with dalcinonacog alfa in adult and pediatric hemophilia B patients
Wednesday 09:45-11:15
I-16 Alan Faraj
A joint ketamine and esketamine exposure-response model of MADRS score in major depressive disorder to enable informed trial design for candidate drugs with similar mode of action
Wednesday 09:45-11:15